Aug 25 (Reuters) - Abbvie Inc ( ABBV ):
* ABBVIE TO ACQUIRE GILGAMESH PHARMACEUTICALS' BRETISILOCIN,
A
NOVEL, INVESTIGATIONAL THERAPY FOR MAJOR DEPRESSIVE DISORDER,
EXPANDING PSYCHIATRY PIPELINE
* ABBVIE INC ( ABBV ) - TO BUY BRETISILOCIN PROGRAM FOR UP TO $1.2
BILLION
* ABBVIE ( ABBV ) - GILGAMESH WILL SPIN OFF A NEW ENTITY THAT WILL
OPERATE
UNDER NAME GILGAMESH PHARMA INC
Source text:
Further company coverage: